SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Suzi Ring
Stay informed with Suzi Ring’s coverage and analysis for Fortune.
Health
The hugely popular weight-loss drugs including Ozempic may cause suicidal thoughts. Europe is investigating
By
Suzi Ring
and
Bloomberg
Health
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
By
Suzi Ring
and
Bloomberg
Health
More than three in five pregnant women in the U.S. are unvaccinated, putting them at risk from the fast-spreading Omicron variant
By
Suzi Ring
and
Bloomberg
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By
Suzi Ring
,
Naomi Kresge
, and others
Health
Pfizer-BioNTech and Moderna jabs perform best in study of COVID booster vaccines
By
Suzi Ring
,
Irina Anghel
, and others
Health
Vaccinated people can also spread the Delta variant, a yearlong U.K. study shows
By
Suzi Ring
and
Bloomberg
Health
COVID-19 cases surge in schools as U.K. waits to offer vaccines to adolescents
By
Suzi Ring
,
James Paton
, and others
Health
AstraZeneca says antibody drug is effective at stopping mild COVID-19 from worsening
By
Suzi Ring
and
Bloomberg
Health
AstraZeneca aims to finally gain FDA approval of its COVID vaccine this fall
By
Suzi Ring
,
Anna Edwards
, and others
Health
Most young people don’t need to worry about COVID-19, major study finds
By
Katharine Gemmell
,
Suzi Ring
, and others
Health
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
By
Suzi Ring
and
Bloomberg
Health
The EU is finalizing a deal with Valneva to purchase its COVID-19 vaccine
By
Alberto Nardelli
,
Suzi Ring
, and others
Health
Johnson & Johnson one-shot COVID jab wins U.K. approval
By
Suzi Ring
and
Bloomberg
Health
AstraZeneca seeks FDA emergency approval after missing target
By
Suzi Ring
and
Bloomberg
Health
Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death
By
Suzi Ring
and
Bloomberg